Literature DB >> 20485688

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.

Robert R Quinn1, Brenda R Hemmelgarn, Raj S Padwal, Martin G Myers, Lyne Cloutier, Peter Bolli, Donald W McKay, Nadia A Khan, Michael D Hill, Jeff Mahon, Daniel G Hackam, Steven Grover, Thomas Wilson, Brian Penner, Ellen Burgess, Finlay A McAlister, Maxime Lamarre-Cliche, Donna McLean, Ernesto L Schiffrin, George Honos, Karen Mann, Guy Tremblay, Alain Milot, Arun Chockalingam, Simon W Rabkin, Martin Dawes, Rhian M Touyz, Kevin D Burns, Marcel Ruzicka, Norman R C Campbell, Michel Vallée, G V Ramesh Prasad, Marcel Lebel, Sheldon W Tobe.   

Abstract

OBJECTIVE: To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension. EVIDENCE: MEDLINE searches were conducted from November 2008 to October 2009 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based on evidence from peer-reviewed full-text articles only. RECOMMENDATIONS: Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis of renovascular and endocrine causes of hypertension, home and ambulatory monitoring, and the use of echocardiography in hypertensive individuals are outlined. Changes to the recommendations for 2010 relate to automated office blood pressure measurements. Automated office blood pressure measurements can be used in the assessment of office blood pressure. When used under proper conditions, an automated office systolic blood pressure of 135 mmHg or higher or diastolic blood pressure of 85 mmHg or higher should be considered analogous to a mean awake ambulatory systolic blood pressure of 135 mmHg or higher and diastolic blood pressure of 85 mmHg or higher, respectively. VALIDATION: All recommendations were graded according to strength of the evidence and voted on by the 63 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. To be approved, all recommendations were required to be supported by at least 70% of task force members. These guidelines will continue to be updated annually.

Entities:  

Mesh:

Year:  2010        PMID: 20485688      PMCID: PMC2886554          DOI: 10.1016/s0828-282x(10)70378-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  38 in total

1.  Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults.

Authors:  W B White; Y A Anwar
Journal:  Blood Press Monit       Date:  2001-04       Impact factor: 1.444

Review 2.  A novel process for updating recommendations for managing hypertension: rationale and methods.

Authors:  K B Zarnke; N R Campbell; F A McAlister; M Levine
Journal:  Can J Cardiol       Date:  2000-09       Impact factor: 5.223

3.  Primary and subsequent coronary risk appraisal: new results from the Framingham study.

Authors:  R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

4.  Comparison between an automated and manual sphygmomanometer in a population survey.

Authors:  Martin G Myers; Natalie H McInnis; George J Fodor; Frans H H Leenen
Journal:  Am J Hypertens       Date:  2008-01-24       Impact factor: 2.689

Review 5.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Authors:  Marie Therese Cooney; Alexandra L Dudina; Ian M Graham
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

6.  Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol.

Authors:  George S Stergiou; Dimitris Tzamouranis; Athanasios Protogerou; Efthimia Nasothimiou; Christos Kapralos
Journal:  Blood Press Monit       Date:  2008-10       Impact factor: 1.444

Review 7.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

Authors:  F G R Fowkes; G D Murray; I Butcher; C L Heald; R J Lee; L E Chambless; A R Folsom; A T Hirsch; M Dramaix; G deBacker; J-C Wautrecht; M Kornitzer; A B Newman; M Cushman; K Sutton-Tyrrell; F G R Fowkes; A J Lee; J F Price; R B d'Agostino; J M Murabito; P E Norman; K Jamrozik; J D Curb; K H Masaki; B L Rodríguez; J M Dekker; L M Bouter; R J Heine; G Nijpels; C D A Stehouwer; L Ferrucci; M M McDermott; H E Stoffers; J D Hooi; J A Knottnerus; M Ogren; B Hedblad; J C Witteman; M M B Breteler; M G M Hunink; A Hofman; M H Criqui; R D Langer; A Fronek; W R Hiatt; R Hamman; H E Resnick; J Guralnik; M M McDermott
Journal:  JAMA       Date:  2008-07-09       Impact factor: 56.272

Review 8.  The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Authors:  Nadia A Khan; Brenda Hemmelgarn; Robert J Herman; Simon W Rabkin; Finlay A McAlister; Chaim M Bell; Rhian M Touyz; Raj Padwal; Lawrence A Leiter; Jeff L Mahon; Michael D Hill; Pierre Larochelle; Ross D Feldman; Ernesto L Schiffrin; Norman R C Campbell; Malcolm O Arnold; Gordon Moe; Tavis S Campbell; Alain Milot; James A Stone; Charlotte Jones; Richard I Ogilvie; Pavel Hamet; George Fodor; George Carruthers; Kevin D Burns; Marcel Ruzicka; Jacques dechamplain; George Pylypchuk; Robert Petrella; Jean-Martin Boulanger; Luc Trudeau; Robert A Hegele; Vincent Woo; Phil McFarlane; Michel Vallée; Jonathan Howlett; Peter Katzmarzyk; Sheldon Tobe; Richard Z Lewanczuk
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

9.  Use of automated office blood pressure measurement to reduce the white coat response.

Authors:  Martin G Myers; Miguel Valdivieso; Alexander Kiss
Journal:  J Hypertens       Date:  2009-02       Impact factor: 4.844

10.  A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.

Authors:  J S Benner; L Erhardt; M Flammer; R A Moller; N Rajicic; K Changela; C Yunis; S B Cherry; Z Gaciong; E S Johnson; M C J M Sturkenboom; J García-Puig; X Girerd
Journal:  Int J Clin Pract       Date:  2008-08-07       Impact factor: 2.503

View more
  17 in total

1.  New recommendations for the use of ambulatory blood pressure monitoring in the diagnosis of hypertension.

Authors:  Norm R C Campbell; Brenda R Hemmelgarn
Journal:  CMAJ       Date:  2012-02-06       Impact factor: 8.262

2.  Why use automated office blood pressure measurements in clinical practice?

Authors:  Emmanuel A Andreadis; Epameinondas T Angelopoulos; Gerasimos D Agaliotis; Athanasios P Tsakanikas; George P Mousoulis
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-09-01

3.  Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative.

Authors:  Sheldon W Tobe; James A Stone; Melissa Brouwers; Onil Bhattacharyya; Kimberly M Walker; Martin Dawes; Jacques Genest; Steven Grover; Gordon Gubitz; David Lau; Andrew Pipe; Peter Selby; Mark S Tremblay; Darren E R Warburton; Richard Ward; Vincent Woo; Lawrence A Leiter; Peter P Liu
Journal:  CMAJ       Date:  2011-09-12       Impact factor: 8.262

Review 4.  Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-05-01

Review 5.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

Review 6.  Automated office blood pressure measurement in primary care.

Authors:  Martin G Myers; Janusz Kaczorowski; Martin Dawes; Marshall Godwin
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

7.  Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Authors:  Sherilyn K D Houle; Theresa L Charrois; Finlay A McAlister; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norman R C Campbell; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2016-10-03

8.  Hypertension management initiative prospective cohort study: comparison between immediate and delayed intervention groups.

Authors:  S W Tobe; M Moy Lum-Kwong; S Von Sychowski; K Kandukur; A Kiss; V Flintoft
Journal:  J Hum Hypertens       Date:  2013-06-13       Impact factor: 3.012

9.  24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: The SAFAR study.

Authors:  Shikai Yu; Chen Chi; Athanase D Protogerou; Michel E Safar; Jacques Blacher; Antonis A Argyris; Efthimia G Nasothimiou; Petros P Sfikakis; Theodore G Papaioannou; Henry Xu; Yi Zhang; Yawei Xu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

10.  Nonadherence to Recommended Guidelines for Blood Pressure Measurement.

Authors:  Jack Levy; Linda M Gerber; Xian Wu; Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.